HLS5 Gene implicated in Huntington's
30 January, 2006The Western Australian Institute for Medical Research (WAIMR) has discovered a link between the HLS5 gene and key aspects of Huntington’s disease and AIDS development, according to an announcement made by BioPharmica.
Curry could halt prostate cancer
17 January, 2006Rutgers, the state university of New Jersey, USA, researchers have found that the curry spice turmeric holds real potential for the treatment and prevention of prostate cancer, particularly when combined with certain vegetables.
Trials in measuring radiation doses accurately
12 January, 2006Researchers have begun trials which will allow radiation doses in computed tomography (CT) scans to be estimated much more accurately.
Study suggests drug may reverse psychosis
01 December, 2005Cannabis, a drug believed to increase the risk of psychosis in users, contains a compound that may be able to reverse psychotic behaviour, Monash researchers have found.
Collaborators seek parasite invasion blockers
18 November, 2005A malaria research team, including WEHI Structural Biologist, Professor Ray Norton, has received a US$1 million grant from the US National Institutes of Health to develop more effective malaria treatments.
Adult stem cells found in uterus
04 November, 2005Dr Caroline Gargett from Monash Institute of Medical Research (MIMR) has discovered adult stem cells in the uterus that can be grown into bone, muscle, fat and cartilage and her research has been hailed as a major medical and scientific development by international reproduction experts.
Carbene work could give cheaper drugs
02 November, 2005Chemists at the University of California, Riverside have synthesised a new class of carbenes - molecules that have unusual carbon atoms - that is expected to have wide applications in the pharmaceutical industry, ultimately resulting in a reduction in the price of drugs.
Insulin synthesis without using E.coli
30 October, 2005If living cell is replaced by a test-tube with DNA and a set of substances, it is possible to get proteins in a more simple and inexpensive way. That was done by Russian biochemists synthesising insulin without help of transgene Escherichia coli.
Development of a quick detection method for complex immune analytes
29 October, 2005An analysis method permitting the simultaneous quantification of numerous parameters in the immune system was recently presented at the Campus Vienna Biocenter. The technology, which has been developed by Bender MedSystems, is based on the principle of a widespread analysis device and thus allows for rapid implementation in daily laboratory life. It thus succeeds in satisfying the growing demand at clinical and pharmaceutical organisations for increasingly efficient analysis methods at favourable costs.
Genes may predict response to ADHD medication
27 October, 2005Testable genetic differences might be used to predict the effectiveness of a medication commonly prescribed to treat attention deficit hyperactivity disorder, a new study suggests.
Oncogene may lead to predictive test
25 October, 2005Researchers at The University of Texas MD Anderson Cancer Centre say they have discovered a potential oncongene in ovarian cancer, which is the leading cause of gynaecological cancer death in US women.
Portable generic risk detection
24 October, 2005A portable biosensing device based on micro- and nanotechnologies is expected to help doctors rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.
Microchips for in vitro diagnostics
21 October, 2005DiagnoSwiss and bioMerieux have signed an exclusive licence agreement for the development and use of DiagnoSwiss electrochemical microchips in human in vitro diagnostics.
Investment to develop pain therapy
20 October, 2005A pain drug development company spun out of The University of Queensland has received a $3.25 million investment commitment to develop its innovative pain therapy.
Salivary bacteria as indicators of oral cancer
18 October, 2005Patients suffering from oral cancer have increased levels of certain bacteria in their saliva, according to research published in the Open Access journal, Journal of Translational Medicine. Six common species of bacteria were found at significantly higher levels in the saliva of patients with oral squamous cell carcinoma (OSCC) than in the saliva of healthy individuals. The researchers were able to use three of the six species as a diagnostic tool to predict more than 80% of oral cancer cases. These preliminary findings indicate that three species of bacteria may be incidentally or causally linked with OSCC, and if so detection of these species could be used as a simple, rapid and non-invasive saliva test to diagnose oral cancer.
